Elevated Expression of Inhibitor of Apoptosis Proteins in Prostate Cancer

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4914-4925

  Krajewska, Maryla ^a   Krajewski, Stan ^a   Banares, Steven ^a   Huang, Xianshu ^a   Turner, Bruce ^b   Bubendorf, Lukas ^h   Kallioniemi, Olli P ^c   Shabaik, Ahmed ^d   Vitiello, Antonella ^e   Peehl, Donna ^f   Gao, Guo Jian ^g   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e R W JOHNSON PHARMACEUTICAL RES I   (United States)

^f STANFORD UNIVERSITY   (United States)

^g BD BIOSCIENCES   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELLULAR INHIBITOR OF APOPTOSIS PROTEIN 1; CELLULAR INHIBITOR OF APOPTOSIS PROTEIN 2; PROBASIN; PROSTATE SPECIFIC ANTIGEN; SURVIVIN; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

APOPTOSIS; ARTICLE; CANCER GRADING; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN DATABASE; PROTEIN EXPRESSION; UPREGULATION; X CHROMOSOME;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL LINE, TUMOR; COHORT STUDIES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; JURKAT CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; TIME FACTORS; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 10744232728     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Denmeade, S. R., Lin. X. S., and Isaacs, J. T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate, 28: 251-265, 1996.
2. Nicholson, D. W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ., 6: 1028-1042, 1999.
3. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. X-linked IAP is a direct inhibitor of cell death proteases. Nature (Lond.), 388: 300-304, 1997.
4. Deveraux, Q. L., and Reed, J. C. IAP family proteins: suppressors of apoptosis. Genes Dev., 13: 239-252, 1999.
5. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., and Ashwell, J. D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science (Wash. DC), 288: 874-877, 2000.
6. Reed, J. C. The survivin saga goes in vivo. J. Clin. Investig., 108: 965-969, 2001.
7. Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J., and de Martin, R. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem., 275: 22064-22068, 2000.
8. Sanna, M. G., Duckett, C. S., Richter, B. W., Thompson, C. B., and Ulevitch, R. J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hlLP. Proc. Natl. Acad. Sci. USA, 95: 6015-6020, 1998.
9. Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, A., Binder, B., and Lipp, J. Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med., 188: 211-216, 1998.
10. Sanna, M. G., de Silva Correia, J., Ducrey, O., Lee, J., Nomoto, K., Schrantz, N., Deveraux, Q. L., and Ulevitch, R. J. IAP supression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol. Cell. Biol., 22: 1754-1766, 2002.
11. La Casse, E. C., Baird, S., Korneluk, R. G., and MacKenzie. A. E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17: 3247-3259, 1998.
12. Reed, J. C., and Bischoff, J. R. BIRinging chromosomes through cell division - and survivin the experience. Cell, 102: 545-548, 2000.
13. Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., Cook, B. P., Dufault, M. R., Ferguson, A. T., Gao, Y., He, T-C., Hermeking, H., Hiraldo, S. K., Hwang, P. M., Lopez, M. A., Luderer, H. F., Mathews, B., Petroziello, J. M., Polyak, K., Zawel, L., Zhang, W., Zhang, X., Zhou, W., Haluska, F. G., Jen, J., Sukumar, S., Landes, G. M., Riggins, G. J., Vogelstein, B., Kinzler, K. W., and Velculescu, V. E. Analysis of human transcriptomes. Nat. Genet., 23: 387-388, 1999.
14. Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., and Dixit, V. M. ML-IAP, a novel inhibitor of apoptosis that is perferentially expressed in human melanomas. Curr. Biol., 10: 1359-1366, 2000.
15. Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A., Andreeff, M., and Reed, J. C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res., 6: 1796-1803, 2000.
16. Sobin, L. H., and Fleming, I. D. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer (Phila.), 80: 1803-1804, 1997.
17. Kononen, J., Bubendorf, L., Kallioniemi, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O-P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
18. Schendel, S., Azimov, R., Pawlowski, K., Godzik, A., Kagan, B., and Reed, J. C. Ion channel activity of the BH3 only Bcl-2 family member, BID. J. Biol. Chem., 274: 21932-21936, 1999.
19. Takahashi, R., Deveraux, Q. L., Tamm, I., Welsh, K., Assa-Munt, N., Salvesen, G. S., and Reed, J. C. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem., 273: 7787-7790, 1998.
20. Roy, N., Deveraux, Q. L., Takashashi. R., Salvesen, G. S., and Reed, J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J., 16: 6914-6925, 1997.
21. Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Oltersdorf, V. N., and Reed, J. C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, and anticancer drugs. Cancer Res., 58: 5315-5320, 1998.
22. Krajewski, S., Krajewska, M., Ellerby, L. M., Welsch, K., Xie, Z., Deveraux, Q. L., Salvesen, G. S., Bredesen, D. E., Rosenthal, R. E., Fiskum, G., and Reed, J. C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA, 96: 5752-5757, 1999.
23. Turner, B. C., Krajewski, S., Krajewska, M., Takayama, S., Gumbs, A. A., Rebbeck, T. R., Carter, D., Haffty, B. G., and Reed, J. C. BAG-I: a novel biomarker predicting long term survival in early-stage breast cancer. J. Clin. Oncol., 19: 992-1000, 2001.
24. Granziero, L., Krajewski, S., Farness, P., Yuan, L., Courtney, M. K., Jackson, M. R., Peterson, P. A., and Vitiello. A. Adoptive immunotherapy prevents prostate cancer in a transgenic animal model. Eur. J. Immunol., 29: 1127-1138, 1999.
25. Krajewski, S., Zapata, J. M., and Reed, J. C. Detection of multiple antigens on Western blots. Anal. Biochem., 236: 221-228, 1996.
26. Greenberg, N. M., DeMayo, F. J., Sheppard, P. C., Barrios, R., Lebovitz, R., Finegold, M., Angelopoulou, R., Dodd, J. G., Duckworth, M. L., and Rosen, J. M. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8: 230-239, 1994.
27. Altieri, D. C., Marchisio, P. C., and Marchisio, P. C. Survivin, apoptosis: an interloper between cell death and cell proliferation in cancer. Lab. Investig., 79: 1327-1333, 1999.
28. Greenberg, N. M., DeMayo F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
29. Isaacs, J. T. Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr. Opin. Oncol., 6: 82-89, 1994.
30. Levkau, B., Garton, K. J., Ferri, N., Kloke, K., Nofer, J. R., Baba, H. A., Raines, E. W., and Breithardt. G. xIAP induces cell-cycle arrest and activates nuclear factor-κB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ. Res., 88: 282-290, 2001.
31. Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R-A., Robbins, P. D., Fernandes-Alnemri, T., Shi, Y., and Alnermi, E. S. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature (Lond.), 410: 112-116, 2001.
32. Liston, P., Fong, W. G., Kelly, N. L., Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W., and Korneluk, R. G. Indentificaiton of XAF1 as an antagonist of XIAP anti-caspase activity. Nat. Cell Biol., 3: 128-133, 2001.
33. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. SMAC, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102: 33-42, 2000.
34. Verhagen, A. M., Silke, J., Ekert, P. G., Pakusch, M., Kaufmann, H., Connolly, L. M., Day, C. L., Tikoo, A., Burke, R., Wrobel, C., Moritz, R. L., Simpson, R. J., and Vaux, D. L. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem., 277: 445-454, 2002.
35. Hedge, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., and Alnemri, E. S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277: 432-438, 2002.
36. Chen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., Reed, J. C., and Ng, S. C. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia, 2: 235-241, 2000.
37. Holcik, M., Yeh, C., Korneluk, R. G., and Chow, T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene, 19: 4174-4177, 2000.
38. Li, F., Ackermann, E., Bennett, C., Rothermel, A., Plescia, J., Tognin, S., Villa, A., Marchisio, P., and Altieri, D. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol., 1: 461-466, 1999.
39. Chen, Z., Naito, M., Hori, S., Mashima, T., Yamori, T., and Tsuruo, T. A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem. Biophys. Res. Commun., 264: 847-854, 1999.
40. Sasaki, H., Sheng, Y., Kotsuji, F., and Tsang, B. K. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res., 60: 5659-5666, 2000
41. Li, J., Feng, Q., Kim, J-M., Schneiderman, D., Liston, P., Li, M., Vanderhyden, B., Faught, W., Fung, M. F., Senterman, M., Korneluk, R. G., and Tsang, B. K. Human ovarian cancer and cisplatin resistane: possible role of inhibitor of apoptosis proteins. Endocrinology, 142: 370-380, 2001.
42. Gordon, G. J., Appasani, K., Parcells, J. P., Mukhopadhyay, N. K., Jaklitsch, M. T., Richards, W. G., Sugarbaker, D. J., and Bueno, R. Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis (Lond.), 23: 1017-1024, 2002.
43. Chai, J., Du, C., Wu, J. W., Kyin, S., Wang, X., and Shi, Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature (Lond.), 406: 855-862, 2000.
44. Huang, Q., Deveraux, Q. L., Maeda, S., Salvesen, G. S., Stennicke, H. R., Hammock, B. D., and Reed, J. C. Evolutionary conservation of apoptosis mechanisms: lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9. Proc. Natl. Acad. Sci. USA, 97: 1427-1432, 2000.
45. Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., and Bhalla, K. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood, 99: 3419-3426, 2002.
46. Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M. T., Kadkhodayan, S., Fairbrother, W. J., and Dixit, V. M. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J. Biol. Chem., 277: 12275-12279, 2002.
47. Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., and Kaufmann, S. H. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J. Biol. Chem., 277: 44236-44243, 2002.
48. Carson, J. P., Behnam, M., Sutton, J. N., Du, C., Wang, X., Hunt, D. F., Weber, M. J., and Kulik, G. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Res., 62: 18-23, 2002.
49. Fulda, S., Wick, W., Weller, M., and Debatin, K. M. Smac agonists sensitize for Apo2L/TRAIL- of anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med., 8: 808-815, 2002.
50. Yang, L., Mashima, T., Sato, S., Mochizuki, M., Sakamoto, H., Yamori, T., Oh-Hara, T., and Tsuruo, T. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res., 63: 831-837, 2003.